On the other hand, all p53 abnormal carcinomas are included in the high-risk prognostic group, except for cases with no myometrial invasion, which are considered at intermediate risk instead; in this way, p53 abnormal endometrioid carcinomas are considered prognostically analogous to serous carcinomas. The gene discussed is TP53; the disease is serous adenocarcinoma.